What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?

Jurriën M. ten Berg; Daniël C. Overduin; Dirk Jan van Ginkel

doi:10.1016/j.jcin.2023.12.024

What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?

Jurriën M. ten Berg^*, Daniël C. Overduin, Dirk Jan van Ginkel

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

Original language	English
Pages (from-to)	419-421
Number of pages	3
Journal	Jacc-Cardiovascular Interventions
Volume	17
Issue number	3
DOIs	https://doi.org/10.1016/j.jcin.2023.12.024
Publication status	Published - 12 Feb 2024

Keywords

DOAC
VKA
antithrombotic treatment
oral anticoagulation
transcatheter aortic valve replacement

Access to Document

10.1016/j.jcin.2023.12.024

Cite this

@article{f4e61967f81241bc965acd07fb46d1db,

title = "What Oral Anticoagulant Is Best After TAVR: Vitamin K Antagonists or Direct Oral Anticoagulants?",

keywords = "DOAC, VKA, antithrombotic treatment, oral anticoagulation, transcatheter aortic valve replacement",

author = "{ten Berg}, {Jurri{\"e}n M.} and Overduin, {Dani{\"e}l C.} and {van Ginkel}, {Dirk Jan}",

year = "2024",

month = feb,

day = "12",

doi = "10.1016/j.jcin.2023.12.024",

language = "English",

volume = "17",

pages = "419--421",

journal = "Jacc-Cardiovascular Interventions",

issn = "1936-8798",

publisher = "Elsevier Science",

number = "3",

}

TY - JOUR

T1 - What Oral Anticoagulant Is Best After TAVR

T2 - Vitamin K Antagonists or Direct Oral Anticoagulants?

AU - ten Berg, Jurriën M.

AU - Overduin, Daniël C.

AU - van Ginkel, Dirk Jan

PY - 2024/2/12

Y1 - 2024/2/12

KW - DOAC

KW - VKA

KW - antithrombotic treatment

KW - oral anticoagulation

KW - transcatheter aortic valve replacement

U2 - 10.1016/j.jcin.2023.12.024

DO - 10.1016/j.jcin.2023.12.024

M3 - Editorial

SN - 1936-8798

VL - 17

SP - 419

EP - 421

JO - Jacc-Cardiovascular Interventions

JF - Jacc-Cardiovascular Interventions

IS - 3

ER -